Modafinil is a type of central nervous stimulant that acts on chemical messengers called neurotransmitters. Researchers believe that it improves cognitive function in patients with depression.
Many people who have depression do also depresse on their memory, concentration, and attention. This can interfere with their recovery and lead to poorer outcomes.
Effects of Modafinil on Working Memory
Modafinil improves working memory in patients with depression who are undergoing the recovery phase of depression. Modvigil 200mg also has a positive effect on fatigue and motivation.
The medication comes as a tablet to take by mouth, usually once daily with or without food. The dose is based on your medical condition and response to treatment.
A warning: Modafinil does in a class of medications call wakefulness-promoting agents (WPAs). It can cause unwanted side effects, including extreme lethargy, difficulty thinking, problems controlling movements, and trouble seeing clearly.
It can also cause withdrawal symptoms if you stop using it suddenly. These include shaking, sweating, chills, nausea, vomiting, and confusion.
It does use to treat excessive sleepiness cause by narcolepsy or shift work sleep disorder (sleepiness during schedule waking hours in people who work at night or on rotating shifts). It can also be use for cancer patients and soldiers who are under high stress. It does also being investigate for use in other conditions, such as age-relate memory decline and Alzheimer’s disease.
Methods
Patients with depression often have problems with concentration, memory, and attention. These deficits tend to persist in the recovery phase and affect patient outcomes such as work functioning and relapse rates.
Cognitive difficulties can also affect a patient’s ability to engage in the treatment, at least initially. In this study, the smart pill Buy Artvigil Online, which does typically use to treat narcolepsy and shift work sleep disorder, was use to treat patients with remitte depression who were experiencing cognitive dysfunction.
Researchers evaluated the effects of a single dose of armodafinil on working memory and information-processing performance in patients with remitted depression. Participants were randomize to receive modafinil (200 mg) or a placebo for 8 weeks.
The results of the study indicated that armodafinil improved memory performance in patients with remitted depression. This finding is a positive development for the treatment of depression. In addition, it shows that symptomatic improvement. That occurs during the early phases of antidepressant therapy may lead to an improvement in working memory.
Results
Many people with depression have problems with concentration, memory, and attention. These deficits tend to persist even in the recovery phase, limiting work. And social functioning and increasing the risk of relapse.
One group of researchers in the United Kingdom, however, has found that a smart pill prescribed for Modvigil – is called armodafinil. It can improve cognitive function in patients who are recovering from depression. In this study, the researchers found that patients. Those who took a dose of modafinil improved their performance on a computerized test of memory and other skills.
These findings are important, as many patients with depression struggle to function at work and in other areas of their lives. They also indicate that modafinil may be a valuable treatment option for patients who have depression. As well as other conditions such as chronic fatigue and idiopathic hypersomnia.
Conclusions
Major depressive disorder (MDD) is a widespread, disabling, and life-limiting condition. While antidepressants can lead to a significant improvement in mood and quality of life. Many patients with MDD still have residual symptoms, including cognitive deficits, preventing their full recovery.
There is considerable heterogeneity in the literature describing the effects of antidepressants on cognition, with neuropsychological measures and subjective self-reports being use as outcome measures. This may be due to negative biases in the appraisal of cognitive function that are known to increase depressive symptomatology [235].
However, it has been recently report that impaired performance on cognitive tests may predict poorer response to treatment with selective serotonin reuptake inhibitors (SSRIs) and dual serotonergic-noradrenergic reuptake inhibitors (SNRIs). The current study explored the potential of modafinil as a therapeutic agent for improving working memory. Cognition in patients in remission from depression.
As an SSRI, modafinil is a potent, reversible inhibitor of the 5-HT1A receptor subtype. The results of this study provide further evidence for the positive impact of armodafinil on working memory in MDD.
